Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads |
|---|---|---|
| Editorial: Misleading and Biased Lancet Editorial on Kashmir: What are the Authors Hiding? Full text  |  PDF Year: 2019, Volume: 4, Issue: 3, September-December |
1886 | 737 |
| Review Article: Biomarkers in immuno-oncology: A review article Full text | PDF Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019 |
2200 | 417 |
| Review Article: Immunotherapy in esophageal cancer – An update Full text | PDF Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019 |
1819 | 382 |
| Original Article: Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India Full text | PDF Year: 2019, Volume: 4, Issue: 3, September-December |
1484 | 678 |
| Original Article: Indian Surgeons’ Perspective Regarding Breast-Conserving Surgery: A Cohort Study Full text | PDF Year: 2019, Volume: 4, Issue: 3, September-December |
1415 | 654 |
| Editorial: Nanobytes Full text | PDF Year: 2019, Volume: 4, Issue: 3, September-December |
1340 | 699 |
| Conference Review: 4 molecular oncology conference (MOSCON): Untangling the genetic code Full text | PDF Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019 |
1124 | 313 |
| Review Article: Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent hybridization and Immunohistochemistry: A meta-analysis with systematic review Full text | PDF Year: 2020, Volume: 5, Issue: 1, January-April |
928 | 479 |
| Review Article: Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology Full text | PDF Year: 2020, Volume: 5, Issue: 1, January-April |
953 | 413 |
| Case Report: Complete metabolic response with letrozole and palbociclib in advanced breast cancer Full text | PDF Year: 2019, Volume: 4, Issue: 3, September-December |
1132 | 229 |
| Review Article: Role of molecular diagnostics in determination of tissue of origin in Cancer of Unknown Primary (CUP) Full text | PDF Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019 |
1008 | 259 |
| Case Report: Chronic myelomonocytic leukemia-1 in a post-renal transplant patient Full text | PDF Year: 2020, Volume: 5, Issue: 1, January-April |
823 | 434 |
| Response to the letter: Artificial intelligence: A new era of technological advancement in oncology care Full text | PDF Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019 |
848 | 405 |
| Case Report: An unusual synchronous association of chronic myeloid leukemia with carcinoma tongue Full text | PDF Year: 2019, Volume: 4, Issue: 1, January-April |
872 | 374 |
| Original Article: Evaluation of prevalence and prognostic significance of human epidermal growth factor receptor 2/neu expression in carcinoma endometrium Full text | PDF Year: 2020, Volume: 5, Issue: 1, January-April |
780 | 458 |
| Original Article: Correlation of Biomarkers and Frozen Section Diagnosis with Paraffin Histopathological Diagnosis in Suspected Ovarian Cancer Full text | PDF Year: 2019, Volume: 4, Issue: 3, September-December |
995 | 229 |
| Editorial: Nanobyte: Molecular and immuno oncology update Full text | PDF Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019 |
759 | 321 |
| Conference Review: Leadership in immuno-oncology network 2 (LION:2) immunotherapy oncology – A present status Full text | PDF Year: 2019, Volume: 4, Issue: 1, January-April |
813 | 181 |
| Editorial: Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun! Full text | PDF Year: 2020, Volume: 5, Issue: 1, January-April |
848 | 133 |
| Letter to Editor: Artificial intelligence: A new era of technological advancement in oncology care Full text | PDF Year: 2019, Volume: 4, Issue: 1, January-April |
699 | 195 |
| Original Article: Special considerations for consent in immuno-oncology – Medic LAWgic recommendations Full text | PDF Year: 2019, Volume: 4, Issue: 1, January-April |
698 | 182 |
| Original Article: Multiple gene silencing in pathway in K562 cells Full text | PDF Year: 2019, Volume: 4, Issue: 1, January-April |
603 | 137 |
| Editorial: Nanobyte – Perspectives and milestones in molecular biology and immuno-oncology Full text | PDF Year: 2019, Volume: 4, Issue: 1, January-April |
433 | 163 |
| Original Article: Oral cancers – Micronuclei as biomarker of genotoxicity a population-based study to establish usable dynamic cut off limits in tobacco users Full text | PDF Year: 2019, Volume: 4, Issue: 1, January-April |
431 | 127 |
| Position Paper: Practical consensus recommendations – Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapy Full text | PDF Year: 2019, Volume: 4, Issue: 1, January-April |
405 | 144 |
